RAC do have a drug that could be sold for AML (40% response rate for those on deaths door with AML). They didn't do follow that pipeline because they want(ed) a buyout (plus other patent reasons) . But the drug has different uses now so the timeline has been extended. It was supposed to be heavily marketed to Pharma and probably sold buy now if Heart Protection (+ other things) didn't come along.
Ann: Race continues Board renewal - appoints new Chair, page-96
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
0.020(1.31%) |
Mkt cap ! $267.5M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.57 | $1.55 | $1.987K | 1.274K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6040 | $1.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.56 | 100 | 1 |
View Market Depth
| Last trade - 10.53am 17/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |